STEM CELL TRANSPLANTATION AS A POSSIBLE STRATEGY FOR TREATING STANDARD THERAPY-RESISTANT ANKYLOSING SPONDYLITIS
https://doi.org/10.14412/1996-7012-2016-4-87-91
Abstract
The authors have analyzed the literature dealing with studies of the efficiency and safety of stem cell transplantation (SCT) in patients with ankylosing spondylitis (AS) through the electronic resources Pubmed and Medline by using the keywords «bone marrow transplantation», «hematopoietic stem cell transplantation», «ankylosing spondylitis», «autoimmune diseases», and «sacroiliac joint biopsy». The paper describes four cases of SCT in AS patients, including transplantation that was carried out in one patient with lymphoma concurrent with AS, in two AS patients without blood cancers, and in one patient with AS concurrent with myeloid leukemia. Drug-free remission was achieved in 3 cases: lymphoma concurrent with AS (n=1), AS concurrent with myeloid leukemia (n=1), and AS without comorbidities (n=1). In addition to an improvement in the course of AS, there were also two cases with clinical presentations of AS after SCT. The given cases show that SCT can be basically used to induce drug-free remission in patients with severe forms of standard therapy-resistant AS. However, the introduction of SCT in clinical practice needs to adjust the technique to the specific features of AS patients.
About the Authors
I. Z. Gaidukova
V.I. Razumovsky Saratov State Medical University
Russian Federation
Russian Federation
Contact: Inna Zurabievna Gaidukova; V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia, 112, Bolshaya Kazachya St., Saratov 410012
V. V. Ushakova
V.I. Razumovsky Saratov State Medical University
Russian Federation
Russian Federation
A. P. Rebrov
V.I. Razumovsky Saratov State Medical University
Russian Federation
Russian Federation
References
1. Эрдес ШФ, Бадокин ВВ, Бочкова АГ и др. О терминологии спондилоартритов. Научно-практическая ревматология. 2015;53(6):657-60 [Erdes ShF, Badokin VV, Bochkova AG, et al. On the terminology of spondyloarthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2015;53(6):657-60 (In Russ.)]. doi:10.14412/1995-4484-2015-657-660.
2. Smolen JS, Braun J, Dougados M, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis. 2014;73:6-16. doi:10.1136/annrheumdis-2013-203419.
3. Гайдукова ИЗ, Ребров АП, Шувалова АА. Ремиссия при анкилозирующем спондилите и аксиальных спондилоартритах: современное понимание проблемы. Современная ревматология. 2016;10(1):48-51 [Gaydukova IZ, Rebrov AP, Shuvalova AA. Remission in ankylosing spondylitis and axial spondyloarthritis: A modern understanding of the problem. Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2016;10(1): 48-51 (In Russ.)]. doi:10.14412/1996-7012-2016-1-48-51.
4. Sieper J, Lenaerts J, Wollenhaupt J, et al. Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2. Ann Rheum Dis. 2014 Jan;73(1):108-13. doi:10.1136/annrheumdis-2013-203460.
5. Kiltz U, Heldmann F, Baraliakos X, Braun J. Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition: are there alternatives? Curr Opin Rheumatol. 2012 May;24(3):252-60. doi:10.1097/BOR.0b013e3283524b82.
6. Rosa SB, Voltarelli JC, Chies JA, et al. The use of stem cells for the treatment of autoimmune diseases. Brazil J Med Biol Res. 2007;40:1579-97. doi:10.1590/S0100-879X2006005000166.
7. Hough RE, Snowden JA, Wulffraat NM. Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective. Br J Haematol. 2005 Feb;128(4):432-59. doi:10.1111/j.1365-2141.2004.05298.x.
8. Pasquini MC, Griffith LM, Arnold DL, et al. Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies. Biol Blood Marrow Transplant. 2010 Aug;16(8):1076-83. doi:10.1016/j.bbmt.2010.03.012.
9. Snowden JA, Passweg J, Moore JJ, et al. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. J Rheumatol. 2004 Mar;31(3):482-8.
10. Wulffraat M, de Kleer I, Brinkman D, et al. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: current results and perspectives. Transplant Proc. 2002 Nov;34(7):2925-6. doi:10.1016/S0041-1345(02)03490-5
11. Sui W, Hou X, Che W, et al. Hematopoietic and mesenchymal stem cell transplantation for severe and refractory systemic lupus erythematosus. Clin Immunol. 2013 Aug;148(2):186-97. doi:10.1016/j.clim.2013.05.014.
12. Jantunen E, Myllykangas-Luosujä rvi R, Kaipiainen-Seppä nen O, et al. Autologous stem cell transplantation in a lymphoma patient with a long history of ankylosing spondylitis. Rheumatology (Oxford). 2000; 39(5):563-4. doi:10.1093/rheumatology/39.5.563
13. Britanova OV, Bochkova AG, Staroverov DB, et al. First autologous hematopoietic SCT for ankylosing spondylitis: a case report and clues to understanding the therapy. Bone Marrow Transplant. 2012 Nov;47(11):1479-81. doi:10.1038/bmt.2012.44.
14. Wang P, Li Y, Huang L, et al. Effects and safety of allogenic mesenchymal stem cell intravenous infusion in active ankylosing spondylitis patients who failed NSAIDs: a 20-week clinical trial. Cell Transplant. 2014; 23(10):1293-303. doi:10.3727/096368913X667727.
15. Yang HK, Moon SJ, Shin JH, et al. Regression of syndesmophyte after bone marrow transplantation for acute myeloid leukemia in a patient with ankylosing spondylitis: a case report. J Med Case Rep. 2012 Aug 21;6:250. doi:10.1186/1752-1947-6-250.
16. Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994 Dec;21(12):2286-91.
17. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994 Dec;21(12):2281-5.
18. Koch B, Kranzhö fer N, Pfreundschu M, et al. First manifestations of seronegative spondylarthropathy following autologous stem cell transplantation in HLA-B27-positive patients. Bone Marrow Transplant. 2000 Sep;26(6):673-5. doi:10.1038/sj.bmt.1702565.
19. Sari I, öztü rk MA, Akkoc N. Treatment of ankylosing spondylitis. Turk J Med Sci. 2015;45(2):416-30. doi:10.3906/sag-1401-79.
20. McGonagle D, Khan MA, MazzoOrtega H. Enthesitis in spondyloarthropathy. Curr Opin Rheumatol. 1999;11:244-50. doi:10.1097/00002281-199907000-00004.
21. Годзенко АА. Нестероидные противовоспалительные препараты: основа лечения анкилозирующего спондилита. Современная ревматология. 2011;5(4):66-8 [Godzenko AA. Nonsteroidal anti-inflammatory drugs: a basis for the treatment of ankylosing spondylitis. Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2011;5(4):66-68. (In Russ.)]. doi:10.14412/1996-7012-2011-702.
22. Marzo-Ortega H, O’Connor P, Emery P, et al. Sacroiliac joint biopsies in early sacroiliitis. Rheumatology (Oxford). 2007 Jul;46(7):1210-1. doi: 10.1093/rheumatology/kem098.
23. Appel H, Kuhne M, Spiekermann S, et al. Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: evaluation of the bone-cartilage interface and subchondral bone marrow. Arthritis Rheum. 2006 Jun;54(6):1805-13. doi:10.1002/art.21907.
24. Francois RJ, Neure L, Sieper J, et al. Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases. Ann Rheum Dis. 2006 Jun;65(6):713-20. doi:10.1136/ard.2005.037465.
25. Mamedov IZ, Britanova OV, Chkalina AV, et al. Individual characterization of stably expanded T cell clones in ankylosing spondylitis patients. Autoimmunity. 2009 Sep;42(6):525-36. doi:10.1080/08916930902960362.
26. Afessa B, Peters SG. Major complications following hematopoietic stem cell transplantation. Semin Respir Crit Care Med. 2006 Jun; 27(3):297-309. doi:10.1055/s-2006-945530.
27. Ikehara S. Bone marrow transplantation: a new strategy for intractable diseases. Drugs Today (Barc). 2002 Feb;38(2):103-11. doi:10.1358/dot.2002.38.2.820106.
28. Mamedov IZ, Britanova OV, Bolotin DA, et al. Quantitative tracking of T cell clones after haematopoietic stem cell transplantation. EMBO Mol Med. 2011 Apr;3(4):201-7. doi:10.1002/emmm.201100129.
29. Ананьева ЛП, Алекперов РТ, Насонов ЕЛ. Мезенхимальные клетки костного мозга – перспективы использования при ревматических болезнях. Научнопрактическая ревматология. 2013;51(1):59-67 [Ananyeva LP, Alekperov RT, Nasonov EL. Bone marrow mesenchymal cells: Promises for use in rheumatic diseases. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2013;51(1):59-67 (In Russ.)]. doi:10.14412/1995-4484-2013-1203.
30. Karia VR, Cuchacovich R, Espinoza LR. Undifferentiated spondyloarthritis following allogeneic stem cell transplantation. BMC Musculoskelet Disord. 2010 Jun 25;11:132. doi:10.1186/1471-2474-11-132.
Review
For citations:
Gaidukova IZ, Ushakova VV, Rebrov AP. STEM CELL TRANSPLANTATION AS A POSSIBLE STRATEGY FOR TREATING STANDARD THERAPY-RESISTANT ANKYLOSING SPONDYLITIS. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2016;10(4):87-91. (In Russ.) https://doi.org/10.14412/1996-7012-2016-4-87-91
Views:
1139
Email this article 